i
i
Up-to-date Information
Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
Fungal diseases and COVID-19
-
March 2, 2022
Details:
-
Corporate Authors:
-
Description:COVID-19-associated fungal infections can lead to severe illness and death. Symptoms of certain fungal diseases can be similar to those of COVID-19, including fever, cough, and shortness of breath. Some patients can have COVID-19 and a fungal infection at the same time. Laboratory testing is necessary to determine if a person has a fungal infection, COVID-19, or both.
COVID-19 likely increases the risk for fungal infections because of its effect on the immune system and because treatments for COVID-19 (like steroids and other drugs) can weaken the body’s defenses against fungi. The most commonly reported fungal infections in patients with COVID-19 include aspergillosis, invasive candidiasis, and mucormycosis (sometimes called by the misnomer ”black fungus.” Fungal infections resistant to antifungal treatment have also been described in patients with severe COVID-19.
Awareness of the possibility of fungal co-infection with COVID-19 is essential to reduce delays in diagnosis and treatment in order to help prevent severe illness and death from these infections.
-
Content Notes:Overview -- COVID-19-associated pulmonary aspergillosis -- COVID-19-associated mucormycosis -- Increased spread of Candida auris during COVID-19 pandemic -- Invasive candidiasis in patients with COVID-19 -- Fungal pneumonias can resemble COVID-19 .
-
Subjects:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: